Genetic variants linked to a rare form of bicuspid aortic valve disease that affects young adults and can lead to dangerous and potentially life-threatening aortic complications have been identified by researchers at UTHealth Houston.
Turnstone charts $75M IPO for TIL cell therapies in drumroll of biotech IPOs this month
Turnstone Biologics plans to list on the Nasdaq in a $75 million raise shortly after a trio of biotechs — Apogee Therapeutics, Sagimet Biosciences and